Key result
STEMI and NSTEMI are linked to significantly higher serum IL-16 levels compared to controls.
Why the study?
Are serum levels of IL-16 elevated in patients with acute myocardial infarction compared to controls?
Observational (n=142)
Are serum levels of IL-16 elevated in patients with acute myocardial infarction compared to controls?
IL-16 levels are significantly elevated in patients with acute myocardial infarction and correlate with markers of inflammation and myocardial injury, suggesting a role in the post-infarction inflammatory response.
Answers are grounded in this paper and cite their sources.
Elevated IL-16 in AMI is hypothesis-generating for inflammatory pathways; prospective studies needed before biomarker or therapeutic consideration.
Interleukin (IL)-16, a polypeptide cytokine, plays a crucial role in the inflammatory process, acting as a chemoattractant for peripheral immune cells and has been linked to various inflammatory diseases. However, its role in patients with acute myocardial infarction (AMI) is unclear.We retrospectively analyzed serum levels of IL-16 in blood of patients with (STEMI, n = 45) and without ST-segment elevation myocardial infarction (NSTEMI, n = 42) compared with controls with excluded coronary artery disease (n = 55). Furthermore, correlation analysis with inflammatory cells, C-reactive protein (CRP) levels, dendritic cell precursors (DCPs), and other clinical and biochemical markers was performed.Compared with controls, patients with STEMI and NSTEMI evidenced higher levels of IL-16 in pg/mL (STEMI: 759.38 ± 471.54, NSTEMI: 677.77 ± 438.8, control: 500.45 ± 432.21; P = .002). IL-16 correlated with CRP (r = 0.26, P = .001), leucocytes (r = 0.38, P < .001), NT-proBNP (r = 0.20, P = .02) and hsTnT (r = 0.25, P = .004). Circulating myeloid DCPs, plasmacytoid DCPs, and total DCPs showed a significant inverse correlation to IL-16 levels (r = -0.21, P = .01; r = -0.23, P = .005; r = -0.26, P = .002, respectively).Interleukin-16 might play an important role in the inflammatory process of patients suffering from AMI and correlates with inflammatory cell activation and clinical and biochemical markers. The cytokine IL-16 might upregulate the proinflammatory response and recruitment of inflammatory cells into infarcted myocardium.
No takes yet. Share an insight, caveat, or question.
Schernthaner et al. (2017) conducted an observational in Acute myocardial infarction (n=142). Acute myocardial infarction (STEMI and NSTEMI) vs. Controls with excluded coronary artery disease was evaluated on Serum levels of IL-16 (pg/mL) (p=.002). Patients with STEMI and NSTEMI had higher serum levels of IL-16 compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: